Follow the people · Insider
Sanjiv Patel
Sanjiv Patel files insider transactions with the SEC as a president and ceo of Relay Therapeutics (RLAY). We hold 3 disclosed purchases and sales filed since 21 July 2020, 2 of them in the last 90 days.
- Files forRLAY
- Disclosed buys and sells3 in all, 2 in the last 90 days
- Last disclosure18 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 20 July 2020 — 17 August 2026President and CEO · Relay Therapeutics (RLAY)104 Form 4 lines · source: SEC Form 4
- Filed 19 May 2021 — 18 May 2022Director · Prothena Corp Public Ltd Co (PRTA)2 Form 4 lines · source: SEC Form 4
Everything they disclosed
106 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 48,199 shares of Relay TherapeuticsSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- was granted 3,056 shares of Relay TherapeuticsSEC Form 48 July 2026Common Stock · traded 30 June 2026 · filed 8 July 2026
- ▼ sold on the open market 48,199 shares of Relay TherapeuticsSEC Form 48 July 2026Common Stock · traded 7 July 2026 · filed 8 July 2026
- was granted 1,450,000 shares of Relay Therapeutics (a derivative holding)SEC Form 415 January 2026Stock Option (Right to Buy) · traded 13 January 2026 · filed 15 January 2026
- was granted 1,450,000 shares of Relay Therapeutics (a derivative holding)SEC Form 415 January 2026Stock Option (Right to Buy) · traded 13 January 2026 · filed 15 January 2026
- was granted 994 shares of Relay TherapeuticsSEC Form 47 January 2026Common Stock · traded 31 December 2025 · filed 7 January 2026
- ▼ sold on the open market 43,168 shares of Relay TherapeuticsSEC Form 47 January 2026Common Stock · traded 6 January 2026 · filed 7 January 2026
- was granted 994 shares of Relay TherapeuticsSEC Form 47 January 2026Common Stock · traded 31 December 2025 · filed 7 January 2026
- ▼ sold on the open market 43,168 shares of Relay TherapeuticsSEC Form 47 January 2026Common Stock · traded 6 January 2026 · filed 7 January 2026
- ▼ sold on the open market 62,073 shares of Relay TherapeuticsSEC Form 44 November 2025Common Stock · traded 3 November 2025 · filed 4 November 2025
- ▼ sold on the open market 42,740 shares of Relay TherapeuticsSEC Form 410 July 2025Common Stock · traded 9 July 2025 · filed 10 July 2025
- ▼ sold on the open market 18,639 shares of Relay TherapeuticsSEC Form 410 July 2025Common Stock · traded 9 July 2025 · filed 10 July 2025
- was granted 5,000 shares of Relay TherapeuticsSEC Form 41 July 2025Common Stock · traded 30 June 2025 · filed 1 July 2025
- ▼ sold on the open market 42,769 shares of Relay TherapeuticsSEC Form 424 April 2025Common Stock · traded 23 April 2025 · filed 24 April 2025
- ▼ sold on the open market 18,653 shares of Relay TherapeuticsSEC Form 424 April 2025Common Stock · traded 23 April 2025 · filed 24 April 2025
- ▼ sold on the open market 140,182 shares of Relay TherapeuticsSEC Form 413 February 2025Common Stock · traded 11 February 2025 · filed 13 February 2025
- was granted 332,465 shares of Relay TherapeuticsSEC Form 413 February 2025Common Stock · traded 11 February 2025 · filed 13 February 2025
- ▼ sold on the open market 75,324 shares of Relay TherapeuticsSEC Form 413 February 2025Common Stock · traded 13 February 2025 · filed 13 February 2025
- ▼ sold on the open market 125,000 shares of Relay TherapeuticsSEC Form 423 January 2025Common Stock · traded 21 January 2025 · filed 23 January 2025
- ▼ sold on the open market 125,000 shares of Relay TherapeuticsSEC Form 423 January 2025Common Stock · traded 22 January 2025 · filed 23 January 2025
- ▼ sold on the open market 125,000 shares of Relay TherapeuticsSEC Form 423 January 2025Common Stock · traded 23 January 2025 · filed 23 January 2025
- was granted 1,105,000 shares of Relay Therapeutics (a derivative holding)SEC Form 414 January 2025Stock Option (Right to Buy) · traded 10 January 2025 · filed 14 January 2025
- ▼ sold on the open market 100,000 shares of Relay TherapeuticsSEC Form 418 December 2024Common Stock · traded 16 December 2024 · filed 18 December 2024
- exercised options over 50,000 shares of Relay Therapeutics (a derivative holding)SEC Form 429 July 2024Stock Option (Right to Buy) · traded 25 July 2024 · filed 29 July 2024
- exercised options over 36,706 shares of Relay Therapeutics (a derivative holding)SEC Form 429 July 2024Stock Option (Right to Buy) · traded 26 July 2024 · filed 29 July 2024
- exercised options over 50,000 shares of Relay TherapeuticsSEC Form 429 July 2024Common Stock · traded 25 July 2024 · filed 29 July 2024
- ▼ sold on the open market 50,000 shares of Relay TherapeuticsSEC Form 429 July 2024Common Stock · traded 25 July 2024 · filed 29 July 2024
- exercised options over 36,706 shares of Relay TherapeuticsSEC Form 429 July 2024Common Stock · traded 26 July 2024 · filed 29 July 2024
- ▼ sold on the open market 36,706 shares of Relay TherapeuticsSEC Form 429 July 2024Common Stock · traded 26 July 2024 · filed 29 July 2024
- was granted 2,108 shares of Relay TherapeuticsSEC Form 41 July 2024Common Stock · traded 30 June 2024 · filed 1 July 2024
- was granted 762,360 shares of Relay TherapeuticsSEC Form 418 January 2024Common Stock · traded 16 January 2024 · filed 18 January 2024
- was granted 1,662 shares of Relay TherapeuticsSEC Form 429 September 2023Common Stock · traded 30 June 2023 · filed 29 September 2023
- exercised options over 14,000 shares of Relay Therapeutics (a derivative holding)SEC Form 49 February 2023Stock Option (Right to Buy) · traded 7 February 2023 · filed 9 February 2023
- exercised options over 14,000 shares of Relay Therapeutics (a derivative holding)SEC Form 49 February 2023Stock Option (Right to Buy) · traded 8 February 2023 · filed 9 February 2023
- exercised options over 14,000 shares of Relay Therapeutics (a derivative holding)SEC Form 49 February 2023Stock Option (Right to Buy) · traded 9 February 2023 · filed 9 February 2023
- exercised options over 14,000 shares of Relay TherapeuticsSEC Form 49 February 2023Common Stock · traded 7 February 2023 · filed 9 February 2023
- ▼ sold on the open market 14,000 shares of Relay TherapeuticsSEC Form 49 February 2023Common Stock · traded 7 February 2023 · filed 9 February 2023
- exercised options over 14,000 shares of Relay TherapeuticsSEC Form 49 February 2023Common Stock · traded 8 February 2023 · filed 9 February 2023
- ▼ sold on the open market 14,000 shares of Relay TherapeuticsSEC Form 49 February 2023Common Stock · traded 8 February 2023 · filed 9 February 2023
- exercised options over 14,000 shares of Relay TherapeuticsSEC Form 49 February 2023Common Stock · traded 9 February 2023 · filed 9 February 2023
- ▼ sold on the open market 14,000 shares of Relay TherapeuticsSEC Form 49 February 2023Common Stock · traded 9 February 2023 · filed 9 February 2023
- gave away 254,554 shares of Relay TherapeuticsSEC Form 431 January 2023Common Stock · traded 28 October 2022 · filed 31 January 2023
- gave away 254,554 shares of Relay TherapeuticsSEC Form 431 January 2023Common Stock · traded 28 October 2022 · filed 31 January 2023
- exercised options over 28,000 shares of Relay Therapeutics (a derivative holding)SEC Form 419 January 2023Stock Option (Right to Buy) · traded 17 January 2023 · filed 19 January 2023
- exercised options over 28,000 shares of Relay Therapeutics (a derivative holding)SEC Form 419 January 2023Stock Option (Right to Buy) · traded 18 January 2023 · filed 19 January 2023
- exercised options over 28,000 shares of Relay Therapeutics (a derivative holding)SEC Form 419 January 2023Stock Option (Right to Buy) · traded 19 January 2023 · filed 19 January 2023
- was granted 701,680 shares of Relay Therapeutics (a derivative holding)SEC Form 419 January 2023Stock Option (Right to Buy) · traded 17 January 2023 · filed 19 January 2023
- was granted 701,680 shares of Relay Therapeutics (a derivative holding)SEC Form 419 January 2023Stock Option (Right to Buy) · traded 17 January 2023 · filed 19 January 2023
- exercised options over 28,000 shares of Relay TherapeuticsSEC Form 419 January 2023Common Stock · traded 17 January 2023 · filed 19 January 2023
- ▼ sold on the open market 28,000 shares of Relay TherapeuticsSEC Form 419 January 2023Common Stock · traded 17 January 2023 · filed 19 January 2023
- exercised options over 28,000 shares of Relay TherapeuticsSEC Form 419 January 2023Common Stock · traded 18 January 2023 · filed 19 January 2023
- ▼ sold on the open market 28,000 shares of Relay TherapeuticsSEC Form 419 January 2023Common Stock · traded 18 January 2023 · filed 19 January 2023
- exercised options over 28,000 shares of Relay TherapeuticsSEC Form 419 January 2023Common Stock · traded 19 January 2023 · filed 19 January 2023
- ▼ sold on the open market 28,000 shares of Relay TherapeuticsSEC Form 419 January 2023Common Stock · traded 19 January 2023 · filed 19 January 2023
- exercised options over 14,000 shares of Relay Therapeutics (a derivative holding)SEC Form 410 November 2022Stock Option (Right to Buy) · traded 8 November 2022 · filed 10 November 2022
- exercised options over 18,175 shares of Relay Therapeutics (a derivative holding)SEC Form 410 November 2022Stock Option (Right to Buy) · traded 10 November 2022 · filed 10 November 2022
- exercised options over 9,825 shares of Relay Therapeutics (a derivative holding)SEC Form 410 November 2022Stock Option (Right to Buy) · traded 10 November 2022 · filed 10 November 2022
- exercised options over 14,000 shares of Relay TherapeuticsSEC Form 410 November 2022Common Stock · traded 8 November 2022 · filed 10 November 2022
- ▼ sold on the open market 14,000 shares of Relay TherapeuticsSEC Form 410 November 2022Common Stock · traded 8 November 2022 · filed 10 November 2022
- exercised options over 18,175 shares of Relay TherapeuticsSEC Form 410 November 2022Common Stock · traded 10 November 2022 · filed 10 November 2022
- ▼ sold on the open market 18,175 shares of Relay TherapeuticsSEC Form 410 November 2022Common Stock · traded 10 November 2022 · filed 10 November 2022
- exercised options over 9,825 shares of Relay TherapeuticsSEC Form 410 November 2022Common Stock · traded 10 November 2022 · filed 10 November 2022
- ▼ sold on the open market 9,825 shares of Relay TherapeuticsSEC Form 410 November 2022Common Stock · traded 10 November 2022 · filed 10 November 2022
- exercised options over 14,000 shares of Relay Therapeutics (a derivative holding)SEC Form 413 October 2022Stock Option (Right to Buy) · traded 11 October 2022 · filed 13 October 2022
- exercised options over 14,000 shares of Relay Therapeutics (a derivative holding)SEC Form 413 October 2022Stock Option (Right to Buy) · traded 12 October 2022 · filed 13 October 2022
- exercised options over 14,000 shares of Relay Therapeutics (a derivative holding)SEC Form 413 October 2022Stock Option (Right to Buy) · traded 13 October 2022 · filed 13 October 2022
- exercised options over 14,000 shares of Relay TherapeuticsSEC Form 413 October 2022Common Stock · traded 11 October 2022 · filed 13 October 2022
- ▼ sold on the open market 14,000 shares of Relay TherapeuticsSEC Form 413 October 2022Common Stock · traded 11 October 2022 · filed 13 October 2022
- exercised options over 14,000 shares of Relay TherapeuticsSEC Form 413 October 2022Common Stock · traded 12 October 2022 · filed 13 October 2022
- ▼ sold on the open market 14,000 shares of Relay TherapeuticsSEC Form 413 October 2022Common Stock · traded 12 October 2022 · filed 13 October 2022
- exercised options over 14,000 shares of Relay TherapeuticsSEC Form 413 October 2022Common Stock · traded 13 October 2022 · filed 13 October 2022
- ▼ sold on the open market 14,000 shares of Relay TherapeuticsSEC Form 413 October 2022Common Stock · traded 13 October 2022 · filed 13 October 2022
- exercised options over 14,000 shares of Relay Therapeutics (a derivative holding)SEC Form 415 September 2022Stock Option (Right to Buy) · traded 13 September 2022 · filed 15 September 2022
- exercised options over 14,000 shares of Relay Therapeutics (a derivative holding)SEC Form 415 September 2022Stock Option (Right to Buy) · traded 14 September 2022 · filed 15 September 2022
- exercised options over 14,000 shares of Relay Therapeutics (a derivative holding)SEC Form 415 September 2022Stock Option (Right to Buy) · traded 15 September 2022 · filed 15 September 2022
- exercised options over 14,000 shares of Relay TherapeuticsSEC Form 415 September 2022Common Stock · traded 13 September 2022 · filed 15 September 2022
- ▼ sold on the open market 14,000 shares of Relay TherapeuticsSEC Form 415 September 2022Common Stock · traded 13 September 2022 · filed 15 September 2022
- exercised options over 14,000 shares of Relay TherapeuticsSEC Form 415 September 2022Common Stock · traded 14 September 2022 · filed 15 September 2022
- ▼ sold on the open market 14,000 shares of Relay TherapeuticsSEC Form 415 September 2022Common Stock · traded 14 September 2022 · filed 15 September 2022
- exercised options over 14,000 shares of Relay TherapeuticsSEC Form 415 September 2022Common Stock · traded 15 September 2022 · filed 15 September 2022
- ▼ sold on the open market 14,000 shares of Relay TherapeuticsSEC Form 415 September 2022Common Stock · traded 15 September 2022 · filed 15 September 2022
- was granted 814 shares of Relay TherapeuticsSEC Form 48 July 2022Common Stock · traded 30 June 2022 · filed 8 July 2022
- was granted 15,000 shares of Prothena Corp Public Ltd Co (a derivative holding)SEC Form 427 May 2022Stock Option (Right to Buy) · traded 18 May 2022 · filed 27 May 2022
- exercised options over 28,000 shares of Relay Therapeutics (a derivative holding)SEC Form 414 April 2022Stock Option (Right to Buy) · traded 12 April 2022 · filed 14 April 2022
- exercised options over 14,000 shares of Relay Therapeutics (a derivative holding)SEC Form 414 April 2022Stock Option (Right to Buy) · traded 13 April 2022 · filed 14 April 2022
- exercised options over 14,000 shares of Relay Therapeutics (a derivative holding)SEC Form 414 April 2022Stock Option (Right to Buy) · traded 13 April 2022 · filed 14 April 2022
- exercised options over 14,000 shares of Relay Therapeutics (a derivative holding)SEC Form 414 April 2022Stock Option (Right to Buy) · traded 14 April 2022 · filed 14 April 2022
- exercised options over 14,000 shares of Relay Therapeutics (a derivative holding)SEC Form 414 April 2022Stock Option (Right to Buy) · traded 14 April 2022 · filed 14 April 2022
- exercised options over 28,000 shares of Relay TherapeuticsSEC Form 414 April 2022Common Stock · traded 12 April 2022 · filed 14 April 2022
- ▼ sold on the open market 28,000 shares of Relay TherapeuticsSEC Form 414 April 2022Common Stock · traded 12 April 2022 · filed 14 April 2022
- exercised options over 14,000 shares of Relay TherapeuticsSEC Form 414 April 2022Common Stock · traded 13 April 2022 · filed 14 April 2022
- ▼ sold on the open market 14,000 shares of Relay TherapeuticsSEC Form 414 April 2022Common Stock · traded 13 April 2022 · filed 14 April 2022
- exercised options over 14,000 shares of Relay TherapeuticsSEC Form 414 April 2022Common Stock · traded 13 April 2022 · filed 14 April 2022
- ▼ sold on the open market 14,000 shares of Relay TherapeuticsSEC Form 414 April 2022Common Stock · traded 13 April 2022 · filed 14 April 2022
- exercised options over 14,000 shares of Relay TherapeuticsSEC Form 414 April 2022Common Stock · traded 14 April 2022 · filed 14 April 2022
- ▼ sold on the open market 14,000 shares of Relay TherapeuticsSEC Form 414 April 2022Common Stock · traded 14 April 2022 · filed 14 April 2022
- exercised options over 14,000 shares of Relay TherapeuticsSEC Form 414 April 2022Common Stock · traded 14 April 2022 · filed 14 April 2022
- ▼ sold on the open market 14,000 shares of Relay TherapeuticsSEC Form 414 April 2022Common Stock · traded 14 April 2022 · filed 14 April 2022
- was granted 527,140 shares of Relay Therapeutics (a derivative holding)SEC Form 431 January 2022Stock Option (Right to Buy) · traded 27 January 2022 · filed 31 January 2022
- was granted 658 shares of Relay TherapeuticsSEC Form 47 January 2022Common Stock · traded 31 December 2021 · filed 7 January 2022
- was granted 30,000 shares of Prothena Corp Public Ltd Co (a derivative holding)SEC Form 421 May 2021Stock Option (Right to Buy) · traded 19 May 2021 · filed 21 May 2021
- gave away 150,000 shares of Relay TherapeuticsSEC Form 426 March 2021Common Stock · traded 16 February 2021 · filed 26 March 2021
- gave away 150,000 shares of Relay TherapeuticsSEC Form 426 March 2021Common Stock · traded 16 February 2021 · filed 26 March 2021
- was granted 325,000 shares of Relay Therapeutics (a derivative holding)SEC Form 426 March 2021Stock Option (Right to Buy) · traded 26 March 2021 · filed 26 March 2021
- was granted 753,804 shares of Relay Therapeutics (a derivative holding)SEC Form 415 December 2020Stock Option (Right to Buy) · traded 11 December 2020 · filed 15 December 2020
- ▲ bought on the open market 25,000 shares of Relay TherapeuticsSEC Form 421 July 2020Common Stock · traded 20 July 2020 · filed 21 July 2020
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.